Skip to content

Impact of injection solution on the resection status of colonic polyps - Comparison of NaCl versus glycerosteril ® with indigocarmin

Impact of injection solution on the resection status of colonic polyps - Comparison of NaCl versus glycerosteril ® with indigocarmin - EIResKol-17

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
DRKS
Registry ID
DRKS00012741
Enrollment
370
Registered
2017-07-20
Start date
2017-07-24
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

D12.0 D12.1 D12.2 D12.3 D12.4 D12.5 D12.6 D12.7 D12.8

Interventions

Group 1: Submucosal injection with glycerosteril ® + indigocarmine (0.032 mg / ml) + adrenaline (1: 100.000) - subsequently polypectomy followed by biopsies of the resection margin Group 2: Submucosal

Sponsors

Universitätsklinikum Würzburg, Med. Klinik II, Gastroenterologie
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: - patients undergoing diagnostic Ileo colonoscopy - patients undergoing colonoscopy in cancer care - patients with planned polypectomy (polyps known from preliminary examination) - patients with the indication for ablation of sessile (Paris 0-Is) or flat Polypes (Paris 0-IIa) of 8mm to 25mm diameter, performed by using a injection solution (decision is made by the physician) - Good communication with the doctor and all the requirements of the study - Existence of written consent on the day before the investigation

Exclusion criteria

Exclusion criteria: - therapeutic ileo-colonoscopy in cases of serious diseases and interventions in the gastrointestinal tract (bleeding, decompression e.g. in tumor stenosis) - so called emergency endoscopies - patients with chronic inflammatory diseases (Crohn's disease or ulcerative colitis) - serious acute and chronic organ disease requiring treatment (e.g. renal replacement treatment) - Patients with an increased risk of bleeding (e.g., therapeutic anticoagulation with Vit-K antagonists, NOAKs, coagulation disorders), which exclude a polypectomy - the decision is made by the performing physician (for polypectomies are commonly required a platelet count of 50,000 / µl, as well as a pTT 50%) - Drug or alcohol abuse - Pregnancy - Intellectual impairment, which limits the ability to meet all study requirements

Design outcomes

Primary

MeasureTime frame
(I) The use of a dyed glycerosterol solution (Glycerosteril® 10% with indigocarmine and adrenaline) results in a reduced the rate of incomplete polypectomies (residual cells in the marginal biopsies) in polyps between 8 and 25mm by at least 30%, compared to the standard solution (NaCl with adrenaline).

Secondary

MeasureTime frame
(II) The use of dyed glycerosteril® results in a higher rate of en bloc resections of polyps, up to 25mm, compared to standard the solution (endoscopic and histologic en-boc resection). (III) The polypectomy succeeds more easily due to the stability of submucosal fluid collection and takes less time (subjective assessment of the endoscopist filled in the CRF, time measurement). (IV) Due to the more stable submucosal fluid collection, the rate of acute complications through the polypectomy is no more frequent compared to the standard solution (registration in CRF).

Countries

Germany

Contacts

Public ContactMarkus Brand

Universitätsklinikum Würzburg, Med. Klinik II, Gastroenterologie

brand_m@ukw.de0931-20140201

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026